Ryanair Posts HY Profit; Modestly Raises FY23 Traffic Guidance - Quick Facts

Ryanair Holdings (RYA.L,RYAAY) reported that its profit attributable to equity holders of parent for the half-year ended September 30, 2022 was 1.26 billion euros or 1.1101 euros per share compared to a net loss of 47.6 million euros or 0.0422 euros per share in the previous year.

Pre-Exceptional profit after tax for the period was 1.37 billion euros, compared to a pre-Covid half year profit of 1.15 billion euros, due to record in the second quarter traffic, strong operational reliability and robust summer fares which in the second quarter were 14% up on pre-Covid pricing.

Total operating revenues for the quarter grew to 6.62 billion euros from 2.15 billion euros in the prior year.

Ryanair said, while it remains dependent on Boeing meeting their delivery commitments, especially for Christmas extras and Spring mid-term, the company modestly raised its fiscal year 2023 traffic guidance to 168 million passengers from prior outlook of 166.5 million passengers.

Looking ahead for fiscal year 2023, Ryanair expects that it will minimize its winter losses which would enable the company to deliver an profit after tax (pre-exceptionals) in a range of 1.00 billion euros to 1.20 billion euros.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Integrated energy company Chevron reported Friday that profit for the fourth quarter increased 25 percent from last year, reflecting 17 percent revenue growth amid higher realizations and higher margins on refined product sales. Adjusted earnings per share missed analysts' estimates, while quarterly revenues topped it. Reno, Nevada-based ZLINE Kitchen and Bath has expanded its recall of gas ranges citing serious risk of injury or death from carbon monoxide poisoning, the U.S. Consumer Product Safety Commission announced. The recall now includes about 30,000 units of ZLINE gas ranges, including about 28,000 units... The Food and Drug Administration's independent advisory committee unanimously recommended replacing the current original COVID vaccines used in the U.S. for primary shots with new bivalent omicron shots authorized as boosters, reports said. The committee also considered the proposal for annual COVID vaccination, however, didn't vote on it.
Follow RTT